Related references
Note: Only part of the references are listed.Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients
M. Herberth et al.
MOLECULAR PSYCHIATRY (2011)
Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: No changes in docosahexaenoic acid species
Kei Hamazaki et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2010)
Elevated S100B levels in schizophrenia are associated with insulin resistance
J. Steiner et al.
MOLECULAR PSYCHIATRY (2010)
Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naive schizophrenia patients
P. C. Guest et al.
MOLECULAR PSYCHIATRY (2010)
Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: Long-term effects of perinatal phencyclidine administration
Nevena V. Radonjic et al.
NEUROPHARMACOLOGY (2010)
Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naive Patients with Schizophrenia
Jeffrey K. Yao et al.
PLOS ONE (2010)
Proteome analysis of schizophrenia brain tissue
Daniel Martins-De-Souza et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation
Daniel Martins-de-Souza et al.
BMC PSYCHIATRY (2009)
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
Emilio Fernandez-Egea et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia
Daniel Martins-de-Souza et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2009)
Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease
Gjumrakch Aliev et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis
Daniel Martins-de-Souza et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia
Dorit Ben-Shachar
JOURNAL OF NEURAL TRANSMISSION (2009)
Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism
D. Allan Butterfield et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Antipsychotic Treatment Alters Protein Expression Associated with Presynaptic Function and Nervous System Development in Rat Frontal Cortex
Dan Ma et al.
JOURNAL OF PROTEOME RESEARCH (2009)
A Comparative Proteomics Analysis of Rat Mitochondria from the Cerebral Cortex and Hippocampus in Response to Antipsychotic Medications
Baohu Ji et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia
Daniel Martins-de-Souza et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2009)
Proteomics is not only a biomarker discovery tool
Daniel Martins-de-Souza
PROTEOMICS CLINICAL APPLICATIONS (2009)
Abnormal transbilayer distribution of phospholipids in red blood cell membranes in schizophrenia
Philippe Nuss et al.
PSYCHIATRY RESEARCH (2009)
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2009)
Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study
Edgardo Carrizo et al.
SCHIZOPHRENIA RESEARCH (2009)
Results of phase 3 of the CATIE schizophrenia trial
T. Scott Stroup et al.
SCHIZOPHRENIA RESEARCH (2009)
Isoprostenes as indicators of oxidative stress in schizophrenia
Anna Dietrich-Muszalska et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2009)
The Liver-Brain Axis of Alcohol-Mediated Neurodegeneration: Role of Toxic Lipids
Suzanne M. de la Monte et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2009)
Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: A potential approach to identify atherosclerotic disease progression
Paul A. Gurbel et al.
AMERICAN HEART JOURNAL (2008)
Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma
Hangjun Duan et al.
ARTHRITIS AND RHEUMATISM (2008)
Multianalyte profiling of serum antigens and autoimmune and infectious disease molecules to identify biomarkers dysregulated in epithelial ovarian cancer
Greg P. Bertenshaw et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Hepatic insulin resistance in antipsychotic naive schizophrenic patients: Stable isotope studies of glucose metabolism
Lonneke J. M. van Nimwegen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides
Emanuel Schwarz et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia
Kyla Pennington et al.
PROTEOMICS (2008)
Glucose abnormalities in the siblings of people with schizophrenia
Emilio Fernandez-Egea et al.
SCHIZOPHRENIA RESEARCH (2008)
Biomarker profiles in serum and saliva of experimental Sjogren's syndrome: associations with specific autoimmune manifestations
Nicolas Delaleu et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder
K. Pennington et al.
MOLECULAR PSYCHIATRY (2008)
Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues
J. T-J Huang et al.
MOLECULAR PSYCHIATRY (2008)
Phase I study of eptifibatide in patients with sickle cell anaemia
Sheritha P. Lee et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Insulin and insulin-like growth factor-1 abnormalities in anti psychotic-naive schizophrenia
Ganesan Venkatasubramanian et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Abnormal pathways in the genu of the corpus callosum in schizophrenia pathogenesis: a proteome study
Sinthuja Sivagnanasundaram et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples
Yishai Levin et al.
JOURNAL OF SEPARATION SCIENCE (2007)
Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration:: A multicentric, double-blind, placebo-controlled trial
Trino Baptista et al.
SCHIZOPHRENIA RESEARCH (2007)
Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia
L. M. Spelman et al.
DIABETIC MEDICINE (2007)
Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients
Y. J. La et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Supramolecular structure of the mitochondrial oxidative phosphorylation system
Egbert J. Boekema et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia
Sudhakaran Prabakaran et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Glutamate and schizophrenia: Beyond the dopamine hypothesis
Joseph T. Coyle
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes
Clare L. Beasley et al.
PROTEOMICS (2006)
A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia
D Clark et al.
MOLECULAR PSYCHIATRY (2006)
Higher fasting serum insulin levels are associated with a better psychopathology profile in acutely ill non-diabetic inpatients with schizophrenia
Xiaoduo Fan et al.
SCHIZOPHRENIA RESEARCH (2006)
Altered thalamic membrane phospholipids in schizophrenia: A postmortem study
A Schmitt et al.
BIOLOGICAL PSYCHIATRY (2004)
Schizophrenia, the metabolic syndrome and diabetes
RIG Holt et al.
DIABETIC MEDICINE (2004)
Multiplex proteomic analysis by two-dimensional differential in-gel electrophoresis
MR Knowles et al.
PROTEOMICS (2003)
Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia
MCM Ryan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
New onset diabetes and atypical antipsychotics
KA Liebzeit et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2001)
Oxidative damage and schizophrenia - An overview of the evidence and its therapeutic implications
JK Yao et al.
CNS DRUGS (2001)
Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology
SP Gygi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients
JK Yao et al.
SCHIZOPHRENIA RESEARCH (2000)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder
NL Johnston-Wilson et al.
MOLECULAR PSYCHIATRY (2000)
Share Paper
